Satoshi Nitta
Overview
Explore the profile of Satoshi Nitta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suzuki S, Nagumo Y, Kojo K, Kandori S, Sakurai H, Takahashi R, et al.
BMC Cancer
. 2025 Mar;
25(1):464.
PMID: 40082801
Background: To clarify the long-term prognoses of elderly upper tract urothelial carcinoma (UTUC) patients after surgery. Methods: We used a hospital-based cancer registry data in Japan to extract patients with...
2.
Kandori S, Suzuki S, Kojo K, Isoda B, Tanaka T, Nitta S, et al.
BMC Cancer
. 2025 Jan;
25(1):138.
PMID: 39849400
Background: To identify the prognosis of Japanese patients with collecting duct carcinoma (CDC). Methods: We used a hospital-based cancer registry data in Japan to extract CDC cases that were diagnosed...
3.
Shiga M, Nagumo Y, Kojo K, Kandori S, Takahashi R, Isoda B, et al.
Int J Urol
. 2025 Jan;
PMID: 39749844
Objective: Our study assessed the correlation between discrepancies in clinical and pathological T stages and overall survival (OS) in patients with upper urinary tract urothelial carcinoma (UTUC), including renal pelvis...
4.
Suzuki S, Nagumo Y, Kojo K, Ikeda A, Isoda B, Yamaguchi A, et al.
Photodiagnosis Photodyn Ther
. 2024 Dec;
51:104429.
PMID: 39638220
Background: To investigate variations in diagnostic performance of photodynamic diagnosis (PDD) according to surgical experience. Methods: Data were extracted from patients having pT1 or lower primary tumors that underwent PDD-assisted...
5.
Hamada K, Nagumo Y, Kandori S, Isoda B, Suzuki S, Sano K, et al.
Cancer Sci
. 2024 Nov;
116(2):381-392.
PMID: 39528232
The tumor microenvironment (TME) modulates therapeutic response and prognosis in patients with bladder cancer (BC). The roles of two phospholipase D (PLD) isoforms, PLD1 and PLD2 (hydrolysis of phosphatidylcholine to...
6.
Takahashi R, Nitta S, Kandori S, Suzuki S, Hamada K, Tanuma K, et al.
Int J Clin Oncol
. 2024 Sep;
29(11):1756-1761.
PMID: 39235705
Objectives: Mediastinal germ cell tumors are rare and few large-scale studies on mediastinal germ cell tumors are reported. We aimed to investigate the clinical characteristics and survival outcomes of patients...
7.
Omiya A, Nitta S, Kandori S, Takahashi R, Chihara I, Shiga M, et al.
Clin Genitourin Cancer
. 2024 Jul;
22(5):102149.
PMID: 39079466
No abstract available.
8.
Isoda B, Kandori S, Sazuka T, Kojima T, Nitta S, Shiga M, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000552
Combination therapy of nivolumab and ipilimumab (NIVO + IPI) for metastatic renal cell carcinoma (mRCC) has shown efficacy, but approximately 20% of patients experience disease progression in the early stages...
9.
A Machine Learning Model to Predict the Histology of Retroperitoneal Lymph Node Dissection Specimens
Nitta S, Kojima T, Gido M, Nakagawa S, Kakeya H, Kandori S, et al.
Anticancer Res
. 2024 Apr;
44(5):2151-2157.
PMID: 38677742
Background/aim: While post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) benefits patients with teratoma or viable germ cell tumors (GCT), it becomes overtreatment if necrosis is detected in PC-RPLND specimens. Serum microRNA-371a-3p...
10.
Suzuki S, Nagumo Y, Ikeda A, Kojo K, Nitta S, Chihara I, et al.
Photodiagnosis Photodyn Ther
. 2024 Mar;
46:104052.
PMID: 38508438
Background: Identification of patient subclasses that correlate with the diagnostic performance of photodynamic diagnostic (PDD)-assisted transurethral resection of bladder tumors (TURBT) may improve outcomes. Methods: Data were extracted from patients...